VA Maryland Health Care System
Baltimore, Maryland, 21201, United States
NCT Number: NCT00018421
This randomized trial investigates the hypothesis that regular aerobic exercise training using a task specific gait training modality will improve cardiovascular fitness, functional mobility, and reduce risk factors for recurrent cardiovascular events in chronic hemiparetic stroke patients, when compared to matched controls performing just stretching.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21201, United States
The aims are to determine whether 6 months progressive graded treadmill training: 1) improves cardiovascular fitness levels and reduces the excessive energy demands of hemiparetic gait, as defined by oxygen consumption levels based on open circuit spirometry during peak and submaximal exercise ambulation tasks; 2) increases free living physical activity measured by portable kinematic recording devices and quantitative in vivo determination of energy expenditure using stable isotopes; and, 3) improves the cardiovascular-metabolic risk factor profile including measures of key endogenous fibrinolysis regulatory enzymes [plasma tissue plasminogen activator (t-PA) and its main circulating inhibitor (PAI-1)], fasting lipoprotein lipid profiles, blood pressure, and oral glucose tolerance and insulin responses. Measurements of body composition at baseline and after training will further determine the effects of aerobic exercise training on muscle mass and central obesity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Males or Females Ages 40 yrs to 80 yrs who are chronic hemiparetic stroke patients.
US Department of Veterans Affairs
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04232163
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT02938000
Behavior, Brain Diseases
San Diego, California, United States
View Trial DetailsNCT07336667
Brain Diseases, Cardiovascular Diseases
Seoul, South Korea
View Trial DetailsNCT07685691
Brain Diseases, Cardiovascular Diseases
Adana, Turkey (Türkiye)
View Trial Details